BioStock: WntResearch focuses on recruitment of patients and new CEO

Cancer therapy company WntResearch has reported an eventful first half of the year. With fresh capital and a NeoFox study back at full speed, the focus during the autumn will be on continued recruitment to reach the goal of an interim analysis by the end of 2022. Recruitment is also on the agenda for the company’s Board of Directors, as current acting CEO Anders Rabbe has chosen to move on to new challenges.

Read the full article at biostock.se:

https://www.biostock.se/en/2021/09/wntresearch-focuses-on-recruitment-of-patients-and-new-ceo/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se